Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01560585
Recruitment Status : Terminated
First Posted : March 22, 2012
Last Update Posted : August 28, 2014
Information provided by (Responsible Party):
Alan Lerner, MD, University Hospitals Cleveland Medical Center